Anavex Life Sciences
AVXL
#9426
Rank
S$0.18 B
Marketcap
S$1.96
Share price
2.62%
Change (1 day)
-82.49%
Change (1 year)

Anavex Life Sciences (AVXL) - Net assets

Net assets on the balance sheet as of June 2026 : S$0.14 Billion

According to Anavex Life Sciences 's latest financial reports the company has S$0.14 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Anavex Life Sciences - Net assets on balance sheet (from 2005 to 2026)

Net assets by year

Year Net assets Change
2025-09-30$S$0.12 B-20.8%
2024-09-30$S$0.15 B-20.25%
2023-09-30$S$0.19 B-5.25%
2022-09-30$S$0.20 B-0.15%
2021-09-30$S$0.20 B451.11%
2020-09-30$S$37.16 M32.54%
2019-09-30$S$28.04 M-8.11%
2018-09-30$S$30.52 M-7.41%
2017-09-30$S$32.96 M283.02%
2016-09-30$S$8.6 M-52.8%
2015-09-30$S$18.23 M7318.85%
2014-09-30$S$0.24 M-107.95%
2013-09-30$-S$3.1 Million-12.5%
2012-09-30$-S$3.54 Million138.13%
2011-09-30$-S$1.49 Million-61.89%
2010-09-30$-S$3.9 Million-28.7%
2009-09-30$-S$5.47 Million65.8%
2008-09-30$-S$3.3 Million382.37%
2007-09-30$-S$0.69 Million2672.06%
2006-09-30$-S$0.03 Million-43.99%
2005-09-30$-S$0.05 Million-202.19%
2004-09-30$S$0.04 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Ligand Pharmaceuticals
LGND
S$1.23 B 760.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
S$0.90 B 527.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
S$13.56 M-90.58%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-S$0.59 Billion-504.00%๐Ÿ‡บ๐Ÿ‡ธ USA